| Prophylactic antiarrhythmic therapy of high-risk survivors of myocardial infarction: lower mortality at 1 month but not at 1 year. | |
| | |
MedLine Citation:
|
PMID: 3549043 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
To determine whether prophylactic antiarrhythmic therapy influences mortality in high-risk patients after acute myocardial infarction, 143 such patients were randomized in a double-blind individually dose-adjusted, placebo-controlled trial an average of 14 +/- 7 days after myocardial infarction and followed for 1 year. Patients were judged to be at high risk on the basis of (1) ejection fraction less than 40% (n = 60), (2) arrhythmias of Lown class 3 or higher (n = 26), or (3) both (n = 57). Aprindine was chosen because of its long half-life, few side effects, and antiarrhythmic efficacy. Baseline characteristics in the treatment arms did not differ. Holter-detected arrhythmias were reduced in aprindine-treated patients at 3 months (p less than .001) and at 1 year (p less than .001). One patient was lost to follow-up; in the remaining patients 1 year mortality was 20% (28/142; 12 aprindine and 16 placebo). There was no significant difference between the two study arms in overall mortality and sudden death. However, among those who died, median duration of survival was longer in aprindine-treated patients (86 vs 21.5 days) (p = .04). Although antiarrhythmic treatment with aprindine of high-risk patients after myocardial infarction does not affect 1 year survival, mortality appears to be delayed; thus there may be a role for short-term treatment before more definitive therapy such as surgery. |
| | |
Authors:
|
S H Gottlieb; S C Achuff; E D Mellits; G Gerstenblith; K L Baughman; L Becker; N C Chandra; S Henley; J O Humphries; C Heck |
Related Documents
:
|
10547943 - Ambulatory 24-hour electrocardiographic monitoring following total cavopulmonary connec... 1615873 - Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillatio... 2847843 - An increased risk of relapse in cyclosporin-treated compared with methotrexate-treated ... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Circulation Volume: 75 ISSN: 0009-7322 ISO Abbreviation: Circulation Publication Date: 1987 Apr |
Date Detail:
|
Created Date: 1987-04-30 Completed Date: 1987-04-30 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0147763 Medline TA: Circulation Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 792-9 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aprindine
/
administration & dosage* Arrhythmias, Cardiac / etiology, mortality, prevention & control* Capsules Clinical Trials as Topic Death, Sudden / epidemiology Double-Blind Method Electrocardiography Humans Indenes / administration & dosage* Maryland Monitoring, Physiologic Myocardial Infarction / complications, mortality* Random Allocation Risk Time Factors |
| Grant Support | |
ID/Acronym/Agency:
|
NHLBI17655-10/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Capsules; 0/Indenes; 37640-71-4/Aprindine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Leukotriene antagonist FPL 57231 prevents the acute pulmonary effects of Escherichia coli endotoxin ...
Next Document: Antiarrhythmic efficacy and hemodynamic effects of cibenzoline in patients with nonsustained ventric...